Sponsored Links

Edison Pharmaceuticals Announces FDA Grants EPI-743 Orphan Drug Designation PDF Print E-mail
Pharmacy - Pharma Industry - Biotech Industry
Edison Pharmaceuticals, Inc. announced the United States Food and Drug Administration has granted orphan drug designation to EPI-743 for treatment of inherited mitochondrial respiratory chain diseases. Today, these mitochondrial diseases affect an estimated 60,000 individuals...

Read more: Pharma Industry / Biotech Industry News From Medical News Today